Page last updated: 2024-09-02

deoxyglucose and Benign Neoplasms

deoxyglucose has been researched along with Benign Neoplasms in 153 studies

Research

Studies (153)

TimeframeStudies, this research(%)All Research%
pre-199023 (15.03)18.7374
1990's56 (36.60)18.2507
2000's21 (13.73)29.6817
2010's43 (28.10)24.3611
2020's10 (6.54)2.80

Authors

AuthorsStudies
Aissa, AF; Bhaskar, P; Blaha, CS; Brooks Robey, R; Frolov, MV; Hay, N; Jeon, SM; Kang, S; Nogueira, V; Patra, KC; Ramakrishnan, G; Rho, H; Terry, AR1
Bhansali, MP; Bhansali, PR; Borkar, MR; Chaturbhuj, GU; Muntean, BS; Viola, RE; Wijayasinghe, YS1
Chatterjee, S; Dash, SK; Dey, S; Giri, B; Haldar, S; Manna, R; Mondal, T; Murmu, N; Saha, I; Sarkar, TR1
Ratajczak, K; Stobiecka, M1
Gomori, JM; Harris, T; Katz-Brull, R; Nardi-Schreiber, A; Sapir, G; Sosna, J; Uppala, S1
Huang, H; Li, S; Liu, Y; Luo, Z; Ma, W; Pardeshi, A; Sun, J; Wan, Z; Xu, J; Zhang, Z1
Kumanogoh, A; Okamoto, Y; Sasawatari, S; Toyofuku, T1
Ahmad, S; Farooqui, A; Husain, A; Khanam, A; Rehman, S; Yusuf, MA1
Chevet, E; Eldering, E; Favaro, F; Iurlaro, R; Lucendo, E; Majem, B; Marchetti, S; Muñoz-Pinedo, C; Nadal, E; Püschel, F; Redondo-Pedraza, J; Ricci, JE1
Fujikawa, R; Ito, C; Kira, S; Misumi, M1
Lampidis, TJ; Mesri, EA1
Du, W; Fan, Y; Liu, J; Sun, C; Wang, B; Wang, J; Wu, T; Xie, W; Yang, H; Yao, Z1
Baleja, JD; Degterev, A; Dutta, I; Jhaveri, A; Pattni, BS; Torchilin, V1
Chung, SK; Chung, SS; Yung, KK; Zhang, SQ1
Mathews, EH; Mathews, GE; Meyer, AA1
Branca, JA; Chow, KH; Costa, M; Hasham, MG; Labrie, NJ; Mills, KD; Perkins, BRA; Roopenian, DC; Rosales, C; Sproule, TJ; Stafford, G; Wilson, JJ; Wolf, EE1
Yamada, K1
Floberg, JM; Schwarz, JK1
Binshtock, E; Bookout, AL; Connelly, JP; Fon Tacer, K; Kamiński, MM; Kim, M; Klein, J; Lord, T; Montoya, MC; Oatley, JM; Oatley, MJ; Potts, PR; Pruett-Miller, SM; Ravichandran, R; Tillman, H1
Glenister, A; Hambley, TW; Simone, MI1
Chen, Y; Deng, L; Edwards, CK; Huang, C; Lei, Y; Li, J; Li, Y; Liu, R; Liu, Y; Lu, Y; Wei, Y; Yuan, K1
Axten, JM; Cao, Y; Kumar, R; Kurtoglu, M; Lampidis, TJ; Liu, H; Xi, H1
Kurtoglu, M; Lampidis, TJ; Xi, H1
Boisbrun, M; Cerella, C; Diederich, M; Flament, S; Grillier-Vuissoz, I; Kuntz, S; Mazerbourg, S1
Fukumoto, M; Kunugita, N; Noma, N; Ochiai, Y; Oikawa, T; Sano, Y; Shimura, T1
Hu, J; Li, J; Sun, Y; Wang, F; Wang, S; Zhang, D1
Cheng, G; Dwinell, MB; Hardy, M; Joseph, J; Kalyanaraman, B; McAllister, D; Ouari, O; Zielonka, J1
Hagen, T; Hong, SY1
Chen, TY; Chuang, JH; Hsu, WM; Huang, CC; Lin, LL; Lin, TK; Liou, CW; Wang, PW; Wang, SY1
Kobayashi, H; Matsumoto, K; Nishimura, H; Yoshida, M1
Hirota, K; Perkins, G; Yamaguchi, R1
Ahmad, S; Ashraf, JM; Aslam Yusuf, M; Choi, I; Lee, EJ; Shahab, U; Tabrez, S1
Baudy, AR; Daemen, A; Evangelista, M; Gao, M; Haley, B; Hatzivassiliou, G; Pusapati, RV; Sandoval, W; Settleman, J; Wilson, C1
Barredo, J; Kurtoglu, M; Lampidis, TJ; Leclerc, G; León-Annicchiarico, CL; Liu, H; Liu, X; Merchan, J; Munoz-Pinedo, C1
Edatt, L; Kiran, MS; Kumar, SV; Kunhiraman, H; Poyyakkara, A; Raveendran, V; Sudhakaran, P; Thekkeveedu, S1
Choi, EK; Jang, SJ; Jo, SY; Jung, CL; Lee, C; Mun, H; Oh, JH; Suh, YA1
D'Souza, CJ; Vishwanatha, A1
Chen, Y; Xiong, QF1
Kovar, JL; Olive, DM; Sevick-Muraca, E; Simpson, MA; Volcheck, W1
Kurtoglu, M; Lampidis, TJ1
Lin, X; Ren, J; Wang, X; Zhang, J1
Dwarakanath, B; Jain, V1
Chen, J; Khuri, FR; Liu, T; Liu, X; Sun, SY; Xiong, L; Zhong, D; Zhou, Q; Zhou, W; Zong, Y1
Dwarakanath, BS1
Adhikari, JS; Afrin, F; Dwarakanath, BS; Farooque, A1
Neary, CL; Pastorino, JG1
Bhardwaj, R; Dwarakanath, BS; Sharma, PK; Varshney, R1
Gatenby, RA; Silva, AS1
Aydogan, B; Chaudhary, A; Chmura, SJ; Kurtoglu, M; Li, J; Pelizzari, C; Rajh, T; Wietholt, C1
Carvalheira, JB; Dias, MM; Osório-Costa, F; Rocha, GZ; Ropelle, ER; Rossato, FA; Saad, MJ; Vercesi, AE1
Chang, YT; Samanta, A; Vendrell, M; Yun, SW1
Bertino, JR; DiPaola, RS; Goodin, S; Gounder, MK; Kong, AN; Lin, H; Stein, M1
Ellisman, M; Janssen, E; Kitada, S; Perkins, G; Reed, JC; Yamaguchi, R1
Ajani, J; Cheong, JH; Dennison, JB; Hall, H; Ki Hong, W; Kundra, V; Lee, JS; Liang, J; Lu, Y; Mills, GB; Nguyen-Charles, C; Park, ES; Ravoori, M; Tsavachidou, D; Wa Cheng, K; Zhang, D1
Perkins, G; Yamaguchi, R1
Choi, Y; Lee, JH1
Huo, J; Jin, Z; Lin, X; Pang, Y; Ren, J; Wang, X; Zhang, J; Zhang, W; Zhang, Y1
Bhardwaj, R; Jadon, SP; Sharma, PK; Varshney, R1
Luo, Z; Nitin, N; Samadzadeh, KM; Tikekar, RV1
Chiorean, EG; Dipaola, RS; Jung, DT; Kroll, S; Kurtoglu, M; Lampidis, TJ; Langmuir, VK; Papadopoulos, K; Raez, LE; Ricart, AD; Rocha Lima, CM; Rosenblatt, J; Schlesselman, JJ; Stein, MN; Tolba, K1
Cao, J; Chen, WR; Cui, S; Du, C; Gu, Y; Li, S; Qian, Z; Tian, J; Wan, S; Wang, G1
HUDSON, MT; WOODWARD, GE1
HOGG, JF; NIRENBERG, MW1
BURK, D; LANDAU, BR; LASZLO, J; STENGLE, J1
BROOKS, JL; CHRISTENSEN, E; STEWART, CJ; WICK, AN1
COE, EL; IBSEN, KH; McKEE, RW1
Hiraku, Y; Kawanishi, S; Mizutani, M; Murata, M; Oikawa, S1
Berridge, MV; Kansara, M1
Maity, A; Tuttle, SW1
Fukuda, H; Furumoto, S; Ishiwata, K; Iwata, R; Kawamura, K; Kubota, K1
Kurtoglu, M; Lampidis, TJ; Maher, JC1
Carvalheira, JB; de Souza, CT; Faria, MC; Morari, J; Pauli, JR; Ropelle, ER; Saad, MJ; Ueno, M; Velloso, LA; Zecchin, KG1
Sinkovics, J1
Gao, N; Kurtoglu, M; Lampidis, TJ; Lane, AN; Lehrman, MA; Maher, JC; Savaraj, N; Shang, J; Wangpaichitr, M1
Avilés-Salas, A; Carreño-Fuentes, L; Gallardo-Pérez, JC; Maldonado-Lagunas, V; Marín-Hernández, A; Moreno-Sánchez, R; Rodríguez-Enríquez, S1
Khuri, FR; Liu, X; Marcus, AI; Schafer-Hales, K; Sun, SY; Zhong, D; Zhou, W1
Gillespie, E; Lichtenstein, LM; Schleimer, RP1
Carrasquillo, JA; Larson, SM1
Ahonen, A; Illukka, T; Johansson, R; Kiuru, A; Nordman, E; Paul, R; Roeda, D; Söderström, KO; Solin, O; Talvio, T1
Fukuda, H; Ido, T; Kiyosawa, M; Matsuzawa, T; Sato, T; Takahashi, T; Watanuki, S; Yoshioka, S1
Fowler, JS; Som, P1
Graham, MM; Grunbaum, Z; Harp, GD; Kaplan, HG; Larson, SM; Rasey, JS; Sale, GE; Weiden, PL; Williams, DL1
Jain, VK; Kalia, VK; Otto, FJ1
Darcourt, J; Lagrange, JL; Maublant, J1
Keyes, JW1
Knapp, WH1
Oberhausen, E; Schaefer, A1
Gatenby, RA1
Delbeke, D; Hendrix, B; Kessler, RM; Martin, WH; Ohana, I; Patton, JA; Sandler, MP; Weinfeld, Z1
Lawson, MA1
Ackermann, RJ; Cotton, L; Ficaro, EP; Macfarlane, DJ; Minn, H; Shreve, PD; Wahl, RL1
Castle, VP; Dole, MG; Hernandez, RJ; Hutchinson, RJ; Koeppe, RA; Mitchell, DS; Prakash, D; Shulkin, BL; Ungar, DR1
Larson, SM1
Boland, GW; Dixon, J; Goldberg, MA; Lee, MJ; Mayo-Smith, WW; McNicholas, MM; Mueller, PR1
Leskinen-Kallio, S1
Arimizu, N; Imaseki, K; Itami, J; Okada, J; Oonishi, H; Uno, K; Yoshikawa, K1
Abbott, FD; Drane, WE; Kuperus, JH; Mastin, ST; Nicole, MW1
Alavi, A; Chandramouli, B; Gupta, NC; Kim, CK1
Aisen, AM; Cieslak, RD; Koeppe, RA; Meyer, CR; Quint, LE; Wahl, RL1
Glaspy, JA; Hawkins, R; Hoh, CK; Phelps, ME1
Alpert, NM; Fischman, AJ1
Kubota, K; Kubota, R; Yamada, S1
Delbeke, D; Martin, WH; Patton, JA; Sandler, MP1
Jones, T; Price, P1
Wahl, RL; Zasadny, KR1
Kabelitz, D; Kremer, B; Lode, H; Meinertz, T; Sauerbruch, T; Sterry, W; Strauss, LG1
Ide, M; Kobayashi, S; Mitomi, T; Shohtsu, A; Suzuki, Y; Takagi, S; Yasuda, S1
Bender, H; Biersack, HJ; Kozak, B; Reichel, C; Ruhlmann, J; Schomburg, A; Sommer, T1
Wagner, HN2
Pauwels, EK; Van Wyngaarden, KE1
Kubota, K1
Strauss, LG2
Endo, K; Matsuzaki, H; Sugiyama, S; Suzuki, Y; Tomiyoshi, K1
Ohana, I; Patton, JA; Sandler, MP; Weinfeld, Z1
Lamki, LM1
Benoit, T; Bury, T; Foidart-Willems, J; Hustinx, R; Jerusalem, G; Kaschten, BJ; Paulus, P; Rigo, P1
Bading, JR; Conti, PS; Grafton, ST; Hawley, K; Keppler, J; Lilien, DL1
Raylman, RR; Wahl, RL1
Ide, M; Shohtsu, A; Takagi, S; Yasuda, S1
Kotz, D1
Ichiya, Y1
Kusić, Z; Lacić, M; Maisey, MN1
Brock, CS; Meikle, SR; Price, P1
Deloar, HM; Fujiwara, T; Hayashi, Y; Itoh, M; Kanamaru, R; Miyake, M; Nakamura, T; Takahashi, H; Watabe, H; Yoshioka, T1
Bellemann, ME; Haberkorn, U1
Price, P1
Cronin, V; Galantowicz, P; Nabi, HA1
Hawkins, RA; Hoh, CK1
Fujibayashi, Y; Ishii, Y; Kato, H; Sadato, N; Waki, A; Yano, R; Yokoyama, A; Yonekura, Y1
Adhikari, JS; Dwarakanath, BS; Jain, V1
Fazio, F; Landoni, C; Valind, S; Wollmer, P1
Adhikari, JS; Bauch, T; Chandana, S; Dwarkanath, BS; Jain, V; Muller, WU; Streffer, C; Zolzer, F1
Ingram, DK; Lane, MA; Roth, GS1
Gopinath, PM; Jain, VK; Kalia, VK; Kucheria, K; Naqvi, S1
Jain, VK; Pohlit, W; Purohit, SC1
Minn, H; Paul, R1
Wilson, CB1
Dahlbom, M; Hawkins, RA; Hoffman, EJ; Hoh, CK; Phelps, ME; Rosenqvist, G; Schiepers, C1
Choi, Y; Hawkins, RA; Hoh, CK; Huang, SC; Messa, C; Phelps, ME1
Chen, B; Choi, Y; Dahlbom, M; Glaspy, J; Hawkins, RA; Hoh, C; Maddahi, J; Messa, C; Slamon, D; Tse, N1
Fukumura, T; Ichiya, Y; Jingu, K; Kuwabara, Y; Masuda, K; Otsuka, M; Tahara, T; Yoshikai, T1
Buchsbaum, DJ; Fisher, S; Grossman, HB; Hutchins, GD; Liebert, M; Wahl, RL1
Conti, PS; Strauss, LG1
Matsuzawa, T1
Fukuda, H; Matsuzawa, T; Tateno, Y1
Fukuda, H; Ido, T; Ito, M; Maeda, S; Matsuzawa, T; Takahashi, H; Wakui, A; Yamaguchi, K; Yang, PK1
Miraldi, F1
Johannsen, B1
Ahonen, A; Haaparanta, M; Johansson, R; Paul, R; Roeda, D; Sipilä, H; Solin, O1
Gridley, DS; Kettering, JD; Mantik, DW; Nutter, RL; Slater, JM1
Hatanaka, M1

Reviews

34 review(s) available for deoxyglucose and Benign Neoplasms

ArticleYear
Multifaceted entrancing role of glucose and its analogue, 2-deoxy-D-glucose in cancer cell proliferation, inflammation, and virus infection.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2022, Volume: 156

    Topics: Adenosine Triphosphate; Cell Proliferation; Deoxyglucose; Glucose; Glycolysis; Humans; Inflammation; Neoplasms; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Reactive Oxygen Species; TOR Serine-Threonine Kinases; Virus Diseases

2022
Glycation and Antioxidants: Hand in the Glove of Antiglycation and Natural Antioxidants.
    Current protein & peptide science, 2020, Volume: 21, Issue:9

    Topics: Antigens, Neoplasm; Antioxidants; Cardiovascular Diseases; Deoxyglucose; Diabetes Mellitus, Type 2; Gene Expression Regulation; Glycation End Products, Advanced; Glyoxal; Humans; Lactoylglutathione Lyase; Mitogen-Activated Protein Kinases; Neoplasms; NF-kappa B; Oxidative Stress; Plant Extracts; Polyphenols; Protein Carbonylation; Pyruvaldehyde; Signal Transduction

2020
2-Deoxy-d-glucose exploits increased glucose metabolism in cancer and viral-infected cells: Relevance to its use in India against SARS-CoV-2.
    IUBMB life, 2021, Volume: 73, Issue:10

    Topics: COVID-19; Deoxyglucose; Glucose; Humans; India; Neoplasms; SARS-CoV-2

2021
Aberrant Uptake of a Fluorescent L-Glucose Analogue (fLG) into Tumor Cells Expressing Malignant Phenotypes.
    Biological & pharmaceutical bulletin, 2018, Volume: 41, Issue:10

    Topics: 4-Chloro-7-nitrobenzofurazan; Animals; Deoxyglucose; Diagnostic Imaging; Filaggrin Proteins; Fluorescence; Fluorescent Dyes; Glucose; Humans; Neoplasms; Stereoisomerism

2018
Manipulation of Glucose and Hydroperoxide Metabolism to Improve Radiation Response.
    Seminars in radiation oncology, 2019, Volume: 29, Issue:1

    Topics: Animals; Auranofin; Buthionine Sulfoximine; Deoxyglucose; Glucose; Glycolysis; Humans; Hydrogen Peroxide; Neoplasms; Oxidation-Reduction; Oxidative Stress; Radiation-Sensitizing Agents

2019
Energy restriction mimetic agents to target cancer cells: comparison between 2-deoxyglucose and thiazolidinediones.
    Biochemical pharmacology, 2014, Nov-01, Volume: 92, Issue:1

    Topics: Antineoplastic Agents; Apoptosis; Autophagy; Cell Line, Tumor; Deoxyglucose; Energy Metabolism; Humans; Neoplasms; Thiazolidinediones

2014
2-Deoxy-D-glucose targeting of glucose metabolism in cancer cells as a potential therapy.
    Cancer letters, 2014, Dec-28, Volume: 355, Issue:2

    Topics: Autophagy; Cell Death; Cell Line, Tumor; Deoxyglucose; Glucose; Humans; Molecular Targeted Therapy; Neoplasms; Oxidative Stress

2014
Multifaceted effects of antimetabolite and anticancer drug, 2-deoxyglucose on eukaryotic cancer models budding and fission yeast.
    IUBMB life, 2017, Volume: 69, Issue:3

    Topics: Animals; Antimetabolites, Antineoplastic; Cell Line, Tumor; Deoxyglucose; Drug Screening Assays, Antitumor; Energy Metabolism; Humans; Neoplasms; Schizosaccharomyces

2017
Review: Deoxyglucose compounds labeled with isotopes different from 18-fuoride: is there a future in clinical practice?
    Cancer biotherapy & radiopharmaceuticals, 2008, Volume: 23, Issue:3

    Topics: Animals; Deoxyglucose; Diagnostic Imaging; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Mice; Neoplasm Transplantation; Neoplasms; Pentetic Acid; Positron-Emission Tomography; Radioisotopes; Rhenium; Technetium; Tomography, Emission-Computed, Single-Photon

2008
From delocalized lipophilic cations to hypoxia: blocking tumor cell mitochondrial function leads to therapeutic gain with glycolytic inhibitors.
    Molecular nutrition & food research, 2009, Volume: 53, Issue:1

    Topics: Anthracyclines; Antineoplastic Agents; Cations; Cell Hypoxia; Deoxyglucose; Glycolysis; Humans; Hypoxia; Mitochondria; Neoplasms; Reference Values; Rhodamine 123

2009
Targeting glucose metabolism with 2-deoxy-D-glucose for improving cancer therapy.
    Future oncology (London, England), 2009, Volume: 5, Issue:5

    Topics: Animals; Antineoplastic Agents; Clinical Trials as Topic; Deoxyglucose; Glucose; Humans; Neoplasms

2009
Cytotoxicity, radiosensitization, and chemosensitization of tumor cells by 2-deoxy-D-glucose in vitro.
    Journal of cancer research and therapeutics, 2009, Volume: 5 Suppl 1

    Topics: Animals; Antineoplastic Agents; Deoxyglucose; Humans; In Vitro Techniques; Neoplasms; Radiation Tolerance; Radiation-Sensitizing Agents; Radiotherapy

2009
Protection of normal cells and tissues during radio- and chemosensitization of tumors by 2-deoxy-D-glucose.
    Journal of cancer research and therapeutics, 2009, Volume: 5 Suppl 1

    Topics: Animals; Deoxyglucose; Humans; Neoplasms; Radiation Tolerance; Radiation-Sensitizing Agents

2009
Differential toxic mechanisms of 2-deoxy-D-glucose versus 2-fluorodeoxy-D-glucose in hypoxic and normoxic tumor cells.
    Antioxidants & redox signaling, 2007, Volume: 9, Issue:9

    Topics: Anaerobiosis; Cell Hypoxia; Deoxyglucose; Glycolysis; Humans; Models, Biological; Neoplasms; Oxygen Consumption

2007
Nuclear oncology 1984.
    Seminars in nuclear medicine, 1984, Volume: 14, Issue:4

    Topics: Antibodies, Monoclonal; Antigens, Neoplasm; Bleomycin; Brain Neoplasms; Deoxyglucose; Fluorodeoxyglucose F18; Gallium Radioisotopes; Glioma; Humans; Liver Neoplasms; Male; Melanoma; Melanoma-Specific Antigens; Middle Aged; Neoplasm Proteins; Neoplasms; Tomography, Emission-Computed

1984
[Positron-emission tomography: role of 18F-fluorodeoxyglucose (18FDG) imaging in oncology].
    Bulletin du cancer, 1995, Volume: 82, Issue:8

    Topics: Cell Transformation, Neoplastic; Deoxyglucose; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Gamma Cameras; Humans; Lymphatic Metastasis; Male; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasms; Predictive Value of Tests; Tomography, Emission-Computed

1995
Positron emission tomographic oncology.
    The Western journal of medicine, 1994, Volume: 161, Issue:4

    Topics: Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Neoplasms; Tomography, Emission-Computed

1994
Positron emission tomography in oncology.
    Clinical physiology (Oxford, England), 1994, Volume: 14, Issue:3

    Topics: Carbon Radioisotopes; Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Methionine; Neoplasms; Tomography, Emission-Computed

1994
Use of positron emission tomography in oncology.
    Oncology (Williston Park, N.Y.), 1993, Volume: 7, Issue:7

    Topics: Brain Neoplasms; Breast Neoplasms; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Neoplasms; Tomography, Emission-Computed

1993
Can positron emission tomography (PET) be used to detect subclinical response to cancer therapy? The EC PET Oncology Concerted Action and the EORTC PET Study Group.
    European journal of cancer (Oxford, England : 1990), 1995, Volume: 31A, Issue:12

    Topics: Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Deoxyglucose; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Fluorodeoxyglucose F18; Humans; Neoplasms; Sensitivity and Specificity; Tomography, Emission-Computed; Treatment Outcome

1995
[Cancer diagnosis with positron emission tomography (PET)].
    Kaku igaku. The Japanese journal of nuclear medicine, 1996, Volume: 33, Issue:2

    Topics: Carbon Radioisotopes; Clinical Trials as Topic; Deoxyglucose; Diagnosis, Differential; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Methionine; Neoplasms; Tomography, Emission-Computed

1996
Fluorine-18 deoxyglucose and false-positive results: a major problem in the diagnostics of oncological patients.
    European journal of nuclear medicine, 1996, Volume: 23, Issue:10

    Topics: Artifacts; Deoxyglucose; False Positive Reactions; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Neoplasms; Sensitivity and Specificity; Tomography, Emission-Computed

1996
Oncological applications of positron emission tomography with fluorine-18 fluorodeoxyglucose.
    European journal of nuclear medicine, 1996, Volume: 23, Issue:12

    Topics: Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Neoplasms; Tomography, Emission-Computed

1996
PET and [18F]-FDG in oncology: a clinical update.
    Nuclear medicine and biology, 1996, Volume: 23, Issue:6

    Topics: Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Neoplasms; Tomography, Emission-Computed

1996
[Diagnosis of cancers by FDG-PET].
    Fukuoka igaku zasshi = Hukuoka acta medica, 1997, Volume: 88, Issue:1

    Topics: Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Neoplasm Staging; Neoplasms; Prognosis; Tomography, Emission-Computed

1997
Does fluorine-18 fluorodeoxyglucose metabolic imaging of tumours benefit oncology?
    European journal of nuclear medicine, 1997, Volume: 24, Issue:6

    Topics: Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Medical Oncology; Neoplasms; Tomography, Emission-Computed

1997
[Positron emission tomography].
    Medizinische Monatsschrift fur Pharmazeuten, 1997, Volume: 20, Issue:5

    Topics: Animals; Blood Glucose; Brain Diseases; Deoxyglucose; Energy Metabolism; Fluorodeoxyglucose F18; Humans; Neoplasms; Pharmacokinetics; Receptors, Neurotransmitter; Tomography, Emission-Computed

1997
Caloric restriction in primates and relevance to humans.
    Annals of the New York Academy of Sciences, 2001, Volume: 928

    Topics: Aging; Animals; Biomarkers; Blood Glucose; Body Temperature; Cardiovascular Diseases; Deoxyglucose; Diabetes Mellitus; Diet, Reducing; Drug Evaluation, Preclinical; Energy Intake; Energy Metabolism; Food Deprivation; Garcinia; Humans; Hypoglycemic Agents; Insulin; Insulin Resistance; Lipids; Longevity; Macaca mulatta; Medicine, Ayurvedic; Metformin; Neoplasms; Phytotherapy; Plant Preparations; Primates; Rats; Rats, Inbred F344; Saimiri; Saponins; Triterpenes

2001
PET scanning in oncology.
    European journal of cancer (Oxford, England : 1990), 1992, Volume: 28, Issue:2-3

    Topics: Deoxyglucose; Fluorodeoxyglucose F18; Humans; Methionine; Neoplasms; Tomography, Emission-Computed

1992
The applications of PET in clinical oncology.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1991, Volume: 32, Issue:4

    Topics: Brain Neoplasms; Colorectal Neoplasms; Deoxyglucose; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Neoplasms; Tomography, Emission-Computed

1991
[Positron emitters for the study of tumor metabolism].
    Der Radiologe, 1989, Volume: 29, Issue:7

    Topics: Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Fluorouracil; Humans; Neoplasms; Tomography, Emission-Computed

1989
[Potential use of positron-emission tomography in clinical oncology].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1988, Volume: 15, Issue:4 Pt 2-1

    Topics: Carbon Radioisotopes; Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Fucose; Humans; Methionine; Neoplasms; Tomography, Emission-Computed

1988
Potential of NMR and PET for determining tumor metabolism.
    International journal of radiation oncology, biology, physics, 1986, Volume: 12, Issue:7

    Topics: Brain Neoplasms; Cerebrovascular Circulation; Deoxyglucose; Fluorodeoxyglucose F18; Glucose; Humans; Magnetic Resonance Spectroscopy; Neoplasms; Oxygen Consumption; Tomography, Emission-Computed

1986
Transport of sugars in tumor cell membranes.
    Biochimica et biophysica acta, 1974, Apr-29, Volume: 355, Issue:1

    Topics: Animals; Antigens, Viral; Avian Sarcoma Viruses; Biological Transport; Carbohydrate Metabolism; Carbon Radioisotopes; Cell Line; Cell Membrane; Cell Transformation, Neoplastic; Cricetinae; Cyclic AMP; Cycloheximide; Cytochalasins; Deoxyglucose; Galactose; Glucosamine; Glucose; Hexosephosphates; Isomerism; Kidney; Kinetics; Leukemia Virus, Murine; Mannose; Methylglucosides; Models, Biological; Neoplasms; Puromycin; Temperature; Time Factors

1974

Trials

5 trial(s) available for deoxyglucose and Benign Neoplasms

ArticleYear
A phase I dose-escalation trial of 2-deoxy-D-glucose alone or combined with docetaxel in patients with advanced solid tumors.
    Cancer chemotherapy and pharmacology, 2013, Volume: 71, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Blood Glucose; Deoxyglucose; Docetaxel; Electrocardiography; Female; Humans; Male; Middle Aged; Neoplasms; Taxoids

2013
Standardized uptake values of FDG: body surface area correction is preferable to body weight correction.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1994, Volume: 35, Issue:1

    Topics: Body Surface Area; Body Weight; Deoxyglucose; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Male; Neoplasms; Tomography, Emission-Computed

1994
[Cancer detection with whole-body FDG PET images without attenuation correction].
    Kaku igaku. The Japanese journal of nuclear medicine, 1996, Volume: 33, Issue:4

    Topics: Adult; Aged; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasms; Sensitivity and Specificity; Tomography, Emission-Computed

1996
[Tumor diagnosis using 18F-FDG SPECT].
    Nihon Igaku Hoshasen Gakkai zasshi. Nippon acta radiologica, 1996, Volume: 56, Issue:9

    Topics: Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Gamma Cameras; Humans; Neoplasms; Tomography, Emission-Computed, Single-Photon

1996
Performance study of a miniature gamma ray scintillation vivo probe for tumor localization.
    Annals of nuclear medicine, 1997, Volume: 11, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Citrates; Deoxyglucose; Endoscopes; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Gallium; Gallium Radioisotopes; Gamma Cameras; Humans; Lung Neoplasms; Lymphatic Metastasis; Lymphoma; Male; Middle Aged; Neoplasms; Phantoms, Imaging; Tomography, Emission-Computed

1997

Other Studies

114 other study(ies) available for deoxyglucose and Benign Neoplasms

ArticleYear
A non-catalytic scaffolding activity of hexokinase 2 contributes to EMT and metastasis.
    Nature communications, 2022, 02-16, Volume: 13, Issue:1

    Topics: A Kinase Anchor Proteins; A549 Cells; Animals; Carcinogenesis; Cell Line, Tumor; CHO Cells; Cricetulus; Cyclic AMP-Dependent Protein Kinase RIalpha Subunit; Deoxyglucose; Epithelial-Mesenchymal Transition; Female; Glucose; Glycogen Synthase Kinase 3 beta; Glycosylation; HCT116 Cells; HEK293 Cells; Hexokinase; Humans; Mice; Mice, Inbred BALB C; Myeloid Cell Leukemia Sequence 1 Protein; Neoplasm Metastasis; Neoplasms; NF-E2-Related Factor 2; Phosphorylation; Rats; Snail Family Transcription Factors

2022
A Comprehensive Biological and Synthetic Perspective on 2-Deoxy-d-Glucose (2-DG), A Sweet Molecule with Therapeutic and Diagnostic Potentials.
    Journal of medicinal chemistry, 2022, 03-10, Volume: 65, Issue:5

    Topics: Adenosine Triphosphate; Antiviral Agents; COVID-19; COVID-19 Drug Treatment; Deoxyglucose; Epilepsy; Glycolysis; Humans; Isotope Labeling; Mitochondria; Neoplasms; Positron-Emission Tomography; SARS-CoV-2; Structure-Activity Relationship; Virus Replication

2022
DNA Aptamer Beacon Probe (ABP) for Monitoring of Adenosine Triphosphate Level in SW480 Cancer Cells Treated with Glycolysis Inhibitor 2-Deoxyglucose.
    International journal of molecular sciences, 2023, May-26, Volume: 24, Issue:11

    Topics: Adenosine Triphosphate; Aptamers, Nucleotide; Biosensing Techniques; Deoxyglucose; Glycolysis; Guanosine Triphosphate; Neoplasms; Uridine Triphosphate

2023
[
    Scientific reports, 2019, 12-23, Volume: 9, Issue:1

    Topics: Bacterial Proteins; Carbon Isotopes; Deoxyglucose; Deuterium; Geobacillus stearothermophilus; Glucokinase; Hexokinase; Humans; Kinetics; Magnetic Resonance Spectroscopy; Neoplasms; Phosphorylation; Positron-Emission Tomography; Radiopharmaceuticals; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Stereoisomerism; Substrate Specificity

2019
Co-delivery of 2-Deoxyglucose and a glutamine metabolism inhibitor V9302 via a prodrug micellar formulation for synergistic targeting of metabolism in cancer.
    Acta biomaterialia, 2020, 03-15, Volume: 105

    Topics: Animals; Antineoplastic Agents; Cell Death; Cell Line, Tumor; Cell Proliferation; Deoxyglucose; Drug Liberation; Drug Synergism; Female; Glucose; Glutamine; Humans; Mice, Inbred BALB C; Micelles; Neoplasms; Polyethylene Glycols; Prodrugs; Tissue Distribution

2020
Blockade of
    Journal of immunology (Baltimore, Md. : 1950), 2020, 03-01, Volume: 204, Issue:5

    Topics: Deoxyglucose; Glycosylation; HMGB Proteins; Humans; Immunity, Cellular; Immunotherapy; Interleukin-2; K562 Cells; Neoplasm Proteins; Neoplasms; NK Cell Lectin-Like Receptor Subfamily K; T-Box Domain Proteins; T-Lymphocytes

2020
Starvation and antimetabolic therapy promote cytokine release and recruitment of immune cells.
    Proceedings of the National Academy of Sciences of the United States of America, 2020, 05-05, Volume: 117, Issue:18

    Topics: Activating Transcription Factor 4; Antimetabolites; Cell Death; Deoxyglucose; Epithelial Cells; Gene Expression Regulation; Glucose; Glutamine; HeLa Cells; Humans; Inflammation; Interleukin-6; Interleukin-8; Macrophages; Metformin; Neoplasms; NF-kappa B; Promoter Regions, Genetic; Starvation; Stress, Physiological

2020
Association between a biomarker of glucose spikes, 1,5-anhydroglucitol, and cancer mortality.
    BMJ open diabetes research & care, 2020, Volume: 8, Issue:1

    Topics: Biomarkers; Blood Glucose; Deoxyglucose; Female; Glucose; Humans; Male; Neoplasms

2020
Synthesis of a new deoxyglucose derivative modified near-infrared fluorescent probe for tumor diagnosis.
    Biochemical and biophysical research communications, 2017, 06-24, Volume: 488, Issue:2

    Topics: Animals; Cell Line, Tumor; Deoxyglucose; Fluorescent Dyes; Humans; Mice; Mice, Nude; Molecular Structure; Neoplasms

2017
Targeting energy metabolism of cancer cells: Combined administration of NCL-240 and 2-DG.
    International journal of pharmaceutics, 2017, Oct-30, Volume: 532, Issue:1

    Topics: Antineoplastic Agents; Cell Cycle; Cell Line, Tumor; Cell Survival; Chlorophenols; Deoxyglucose; Drug Interactions; Energy Metabolism; Humans; Liposomes; Neoplasms; Triazoles

2017
Aldo-keto reductases-mediated cytotoxicity of 2-deoxyglucose: A novel anticancer mechanism.
    Cancer science, 2018, Volume: 109, Issue:6

    Topics: Aldehyde Reductase; Aldo-Keto Reductase Family 1 member B10; Animals; Antineoplastic Agents; Caco-2 Cells; Cell Line, Tumor; Cell Survival; Deoxyglucose; Glycolysis; HCT116 Cells; Hep G2 Cells; HT29 Cells; Humans; Male; Mice, Inbred BALB C; Mice, Inbred ICR; Mice, Nude; Neoplasms; Xenograft Model Antitumor Assays

2018
A hypothetical method for controlling highly glycolytic cancers and metastases.
    Medical hypotheses, 2018, Volume: 118

    Topics: Blood Glucose; Cell Proliferation; Cerebrovascular Circulation; Deoxyglucose; Diet, Ketogenic; Glutamine; Glycolysis; Humans; Hypoglycemia; Hypoglycemic Agents; Insulin; Models, Theoretical; Neoplasm Metastasis; Neoplasms

2018
Enhancing the efficacy of glycolytic blockade in cancer cells
    Cancer biology & therapy, 2019, Volume: 20, Issue:2

    Topics: 4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid; Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Deoxyglucose; Drug Synergism; Female; Glycolysis; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Lung Neoplasms; Mice; Mice, Inbred C57BL; Mice, Inbred NOD; Neoplasms; Rad51 Recombinase; Xenograft Model Antitumor Assays

2019
MAGE cancer-testis antigens protect the mammalian germline under environmental stress.
    Science advances, 2019, Volume: 5, Issue:5

    Topics: Animals; Deoxyglucose; DNA Damage; Evolution, Molecular; Female; Gene Expression Regulation, Neoplastic; Germ Cells; Humans; Male; Melanoma-Specific Antigens; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Knockout; Neoplasms; Spermatogenesis; Spermatogonia; Starvation; Stress, Physiological; Testis

2019
A Warburg effect targeting vector designed to increase the uptake of compounds by cancer cells demonstrates glucose and hypoxia dependent uptake.
    PloS one, 2019, Volume: 14, Issue:7

    Topics: 4-Chloro-7-nitrobenzofurazan; Cell Hypoxia; Cell Line, Tumor; Deoxyglucose; Drug Delivery Systems; Glucose; Glucose Transport Proteins, Facilitative; Hexokinase; Humans; Models, Biological; Neoplasm Proteins; Neoplasms

2019
Pyrvinium targets autophagy addiction to promote cancer cell death.
    Cell death & disease, 2013, May-02, Volume: 4

    Topics: AMP-Activated Protein Kinases; Animals; Antineoplastic Agents; Autophagy; Cell Line; Deoxyglucose; Female; HCT116 Cells; HEK293 Cells; HeLa Cells; Humans; Mice; Mice, Inbred BALB C; Microtubule-Associated Proteins; Neoplasms; Pyrvinium Compounds; TOR Serine-Threonine Kinases; Transplantation, Heterologous; Zebrafish

2013
Conversion of 2-deoxyglucose-induced growth inhibition to cell death in normoxic tumor cells.
    Cancer chemotherapy and pharmacology, 2013, Volume: 72, Issue:1

    Topics: Activating Transcription Factor 6; Animals; Antimetabolites, Antineoplastic; Biomarkers; Cell Death; Cell Line, Tumor; Cell Proliferation; Cells, Cultured; Deoxyglucose; eIF-2 Kinase; Glycosylation; Humans; Membrane Proteins; Mice; Neoplasms; Protein Kinase Inhibitors; Protein Processing, Post-Translational; Protein Serine-Threonine Kinases; RNA Interference; Unfolded Protein Response

2013
The wonders of 2-deoxy-D-glucose.
    IUBMB life, 2014, Volume: 66, Issue:2

    Topics: Apoptosis; Autophagy; Deoxyglucose; Endoplasmic Reticulum Stress; Glycosylation; Humans; Hypoxia; Neoplasms; Virus Replication

2014
AKT-mediated enhanced aerobic glycolysis causes acquired radioresistance by human tumor cells.
    Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 2014, Volume: 112, Issue:2

    Topics: Aerobiosis; Cell Death; Chlorpropamide; Deoxyglucose; Glucose; Glucose Transporter Type 1; Glycolysis; HeLa Cells; Hep G2 Cells; Humans; Lactates; Neoplasms; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Radiation Tolerance; Reactive Oxygen Species

2014
Antiproliferative effects of mitochondria-targeted cationic antioxidants and analogs: Role of mitochondrial bioenergetics and energy-sensing mechanism.
    Cancer letters, 2015, Aug-28, Volume: 365, Issue:1

    Topics: Adenosine Triphosphate; Antineoplastic Agents; Antioxidants; Apoptosis; Cations; Cell Proliferation; Cyclic N-Oxides; Deoxyglucose; Dose-Response Relationship, Drug; Drug Synergism; Energy Metabolism; Glycolysis; Humans; MCF-7 Cells; Mitochondria; Neoplasms; Organophosphorus Compounds; Signal Transduction; Superoxide Dismutase; Superoxides; Time Factors

2015
2-Deoxyglucose induces the expression of thioredoxin interacting protein (TXNIP) by increasing O-GlcNAcylation - Implications for targeting the Warburg effect in cancer cells.
    Biochemical and biophysical research communications, 2015, Oct-02, Volume: 465, Issue:4

    Topics: Adenosine Triphosphate; Animals; Carrier Proteins; Cell Line, Tumor; Deoxyglucose; Dogs; Endoplasmic Reticulum Stress; Glycolysis; Glycosylation; HEK293 Cells; Hep G2 Cells; Humans; Madin Darby Canine Kidney Cells; Mice; Neoplasm Proteins; Neoplasms; Thioredoxins; Tumor Microenvironment

2015
Glycolytic inhibitor 2-deoxyglucose simultaneously targets cancer and endothelial cells to suppress neuroblastoma growth in mice.
    Disease models & mechanisms, 2015, Oct-01, Volume: 8, Issue:10

    Topics: Actin Cytoskeleton; Actins; Animals; Apoptosis; bcl-2 Homologous Antagonist-Killer Protein; bcl-2-Associated X Protein; Cell Line, Tumor; Cell Proliferation; Deoxyglucose; Down-Regulation; Endothelial Cells; Glycolysis; Hypoxia-Inducible Factor 1, alpha Subunit; Immunohistochemistry; Mice, Inbred NOD; Mice, SCID; Neoplasms; Neuroblastoma; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins c-myc; Pseudopodia; Pyruvate Dehydrogenase Acetyl-Transferring Kinase; Xenograft Model Antitumor Assays

2015
Identification of the determinants of 2-deoxyglucose sensitivity in cancer cells by shRNA library screening.
    Biochemical and biophysical research communications, 2015, Nov-06, Volume: 467, Issue:1

    Topics: Antineoplastic Agents; Biological Transport, Active; Cell Line, Tumor; Coatomer Protein; Deoxyglucose; Drug Resistance, Neoplasm; Drug Synergism; Enzyme Inhibitors; Gene Knockdown Techniques; Gene Library; Glycolysis; HCT116 Cells; HeLa Cells; Humans; Lipase; Lipid Metabolism; Neoplasms; Phenylurea Compounds; RNA, Small Interfering

2015
Targeting cholesterol with β-cyclodextrin sensitizes cancer cells for apoptosis.
    FEBS letters, 2015, Dec-21, Volume: 589, Issue:24 Pt B

    Topics: 2-Hydroxypropyl-beta-cyclodextrin; Aniline Compounds; Animals; Anticholesteremic Agents; Antimetabolites; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Apoptosis Regulatory Proteins; beta-Cyclodextrins; Cell Line, Tumor; Crosses, Genetic; Deoxyglucose; Drug Synergism; Humans; Mice, Inbred NOD; Mice, SCID; Neoplasms; Specific Pathogen-Free Organisms; Sulfonamides; Tumor Burden; Xenograft Model Antitumor Assays

2015
DNA Glycation from 3-Deoxyglucosone Leads to the Formation of AGEs: Potential Role in Cancer Auto-antibodies.
    Cell biochemistry and biophysics, 2016, Volume: 74, Issue:1

    Topics: Animals; Antibodies, Neoplasm; Autoantibodies; Case-Control Studies; Deoxyglucose; DNA, Neoplasm; Female; Glycation End Products, Advanced; Humans; Neoplasms; Rabbits

2016
mTORC1-Dependent Metabolic Reprogramming Underlies Escape from Glycolysis Addiction in Cancer Cells.
    Cancer cell, 2016, Apr-11, Volume: 29, Issue:4

    Topics: Adenosine Triphosphate; Animals; Carcinoma; Cell Line, Tumor; Citric Acid Cycle; Combined Modality Therapy; Cytokines; Deoxyglucose; Drug Resistance, Neoplasm; Drug Synergism; Energy Metabolism; Everolimus; Female; Glucose-6-Phosphate Isomerase; Glutaminase; Glutamine; Glycolysis; Hep G2 Cells; Humans; Mechanistic Target of Rapamycin Complex 1; Metabolomics; Mice; Mice, Nude; Molecular Targeted Therapy; Multiprotein Complexes; Neoplasm Proteins; Neoplasms; Ovarian Neoplasms; Pentose Phosphate Pathway; Ribosomal Protein S6 Kinases, 70-kDa; RNA Interference; RNA, Small Interfering; TOR Serine-Threonine Kinases; Tumor Stem Cell Assay; Xenograft Model Antitumor Assays

2016
Combining 2-deoxy-D-glucose with fenofibrate leads to tumor cell death mediated by simultaneous induction of energy and ER stress.
    Oncotarget, 2016, Jun-14, Volume: 7, Issue:24

    Topics: Adenosine Triphosphate; AMP-Activated Protein Kinases; Animals; Apoptosis; Cell Line, Tumor; Deoxyglucose; Drug Synergism; Endoplasmic Reticulum Chaperone BiP; Endoplasmic Reticulum Stress; Eukaryotic Initiation Factor-2; Female; Fenofibrate; Glycolysis; Heat-Shock Proteins; Humans; Hypolipidemic Agents; Mice, Nude; Neoplasms; TOR Serine-Threonine Kinases; Xenograft Model Antitumor Assays

2016
2-Deoxy Glucose Modulates Expression and Biological Activity of VEGF in a SIRT-1 Dependent Mechanism.
    Journal of cellular biochemistry, 2017, Volume: 118, Issue:2

    Topics: Animals; Chick Embryo; Deoxyglucose; Gene Expression Regulation, Neoplastic; Glycolysis; HeLa Cells; Humans; Neoplasm Proteins; Neoplasms; Neovascularization, Pathologic; Sirtuin 1; Vascular Endothelial Growth Factor A

2017
Suppression of gain-of-function mutant p53 with metabolic inhibitors reduces tumor growth in vivo.
    Oncotarget, 2016, Nov-22, Volume: 7, Issue:47

    Topics: A549 Cells; Animals; Cell Line, Tumor; Cell Movement; Cell Proliferation; Deoxyglucose; Gene Expression Regulation, Neoplastic; Gene Knock-In Techniques; Humans; MAP Kinase Signaling System; Mice; Mutation; Neoplasm Metastasis; Neoplasms; Phenformin; Tumor Suppressor Protein p53; Xenograft Model Antitumor Assays

2016
Characterization and performance of a near-infrared 2-deoxyglucose optical imaging agent for mouse cancer models.
    Analytical biochemistry, 2009, Jan-15, Volume: 384, Issue:2

    Topics: Animals; Cell Line, Tumor; Deoxyglucose; Diagnostic Imaging; Fluorescent Dyes; Fluoroimmunoassay; Humans; Indoles; Male; Mice; Mice, Nude; Microscopy, Fluorescence; Neoplasms; Spectroscopy, Near-Infrared; Xenograft Model Antitumor Assays

2009
Synthesis and biological evaluation of a novel (99m)Tc nitrido radiopharmaceutical with deoxyglucose dithiocarbamate, showing tumor uptake.
    Bioorganic & medicinal chemistry letters, 2009, May-15, Volume: 19, Issue:10

    Topics: Animals; Carbamates; Deoxyglucose; Isotope Labeling; Mice; Neoplasms; Organotechnetium Compounds; Radionuclide Imaging; Radiopharmaceuticals; Tissue Distribution

2009
The glycolytic inhibitor 2-deoxyglucose activates multiple prosurvival pathways through IGF1R.
    The Journal of biological chemistry, 2009, Aug-28, Volume: 284, Issue:35

    Topics: Cell Line, Tumor; Cell Survival; Deoxyglucose; Glycolysis; Humans; Neoplasms; Phosphorylation; Receptor, IGF Type 1; Signal Transduction

2009
Nucleocytoplasmic shuttling of hexokinase II in a cancer cell.
    Biochemical and biophysical research communications, 2010, Apr-16, Volume: 394, Issue:4

    Topics: Active Transport, Cell Nucleus; Cell Nucleus; Cytoplasm; Deoxyglucose; Exportin 1 Protein; Fatty Acids, Unsaturated; Glucose; HeLa Cells; Hexokinase; Humans; Karyopherins; Neoplasms; Receptors, Cytoplasmic and Nuclear

2010
Metabolic oxidative stress induced by a combination of 2-DG and 6-AN enhances radiation damage selectively in malignant cells via non-coordinated expression of antioxidant enzymes.
    Cancer letters, 2010, Sep-28, Volume: 295, Issue:2

    Topics: 6-Aminonicotinamide; Antioxidants; Catalase; Cell Line, Tumor; Deoxyglucose; Glutathione; Glutathione Peroxidase; Glutathione Reductase; Humans; NADP; Neoplasms; Oxidative Stress; Radiation Tolerance; Superoxide Dismutase

2010
A theoretical quantitative model for evolution of cancer chemotherapy resistance.
    Biology direct, 2010, Apr-20, Volume: 5

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Deoxyglucose; Drug Resistance, Neoplasm; Humans; Maximum Tolerated Dose; Models, Theoretical; Neoplasms

2010
A novel functional CT contrast agent for molecular imaging of cancer.
    Physics in medicine and biology, 2010, Aug-07, Volume: 55, Issue:15

    Topics: Biological Transport; Cell Line, Tumor; Contrast Media; Deoxyglucose; Gold; Humans; Metal Nanoparticles; Microscopy, Electron, Transmission; Neoplasms; X-Ray Microtomography

2010
Metformin amplifies chemotherapy-induced AMPK activation and antitumoral growth.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2011, Jun-15, Volume: 17, Issue:12

    Topics: AMP-Activated Protein Kinases; Animals; Antimetabolites; Antineoplastic Agents; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Survival; Deoxyglucose; Drug Synergism; Enzyme Activation; Humans; Hypoglycemic Agents; Male; Metformin; Mice; Mice, SCID; Neoplasms; Paclitaxel; Signal Transduction; TOR Serine-Threonine Kinases; Xenograft Model Antitumor Assays

2011
Synthesis and characterization of a cell-permeable near-infrared fluorescent deoxyglucose analogue for cancer cell imaging.
    Organic & biomolecular chemistry, 2011, Jul-07, Volume: 9, Issue:13

    Topics: Carbocyanines; Cell Line, Tumor; Cell Membrane Permeability; Deoxyglucose; Fluorescent Dyes; Glucosamine; Humans; Indoles; Molecular Structure; Neoplasms; Spectroscopy, Near-Infrared

2011
A validated bioanalytical HPLC method for pharmacokinetic evaluation of 2-deoxyglucose in human plasma.
    Biomedical chromatography : BMC, 2012, Volume: 26, Issue:5

    Topics: Antimetabolites, Antineoplastic; Chromatography, High Pressure Liquid; Deoxyglucose; Drug Stability; Fluorescent Dyes; Humans; Limit of Detection; Neoplasms; Reproducibility of Results; Sensitivity and Specificity

2012
Efficient elimination of cancer cells by deoxyglucose-ABT-263/737 combination therapy.
    PloS one, 2011, Volume: 6, Issue:9

    Topics: Aniline Compounds; Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Biphenyl Compounds; Blotting, Western; Cell Line, Tumor; Cytochromes c; Deoxyglucose; Dose-Response Relationship, Drug; HeLa Cells; Hep G2 Cells; Humans; Male; Mice; Mice, Knockout; Mice, Nude; Mitochondria; Myeloid Cell Leukemia Sequence 1 Protein; Neoplasms; Nitrophenols; Piperazines; Proto-Oncogene Proteins c-bcl-2; Sulfonamides; Survival Analysis; Tumor Burden; Xenograft Model Antitumor Assays

2011
Dual inhibition of tumor energy pathway by 2-deoxyglucose and metformin is effective against a broad spectrum of preclinical cancer models.
    Molecular cancer therapeutics, 2011, Volume: 10, Issue:12

    Topics: Animals; Deoxyglucose; Down-Regulation; Drug Evaluation, Preclinical; Energy Metabolism; Female; Humans; Hypoglycemic Agents; Metformin; Mice; Mice, Nude; Neoplasms; Signal Transduction; Treatment Outcome; Tumor Cells, Cultured; Xenograft Model Antitumor Assays

2011
Finding a Panacea among combination cancer therapies.
    Cancer research, 2012, Jan-01, Volume: 72, Issue:1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Deoxyglucose; Drug Delivery Systems; Humans; Neoplasms

2012
The combination of tephrosin with 2-deoxy-D-glucose enhances the cytotoxicity via accelerating ATP depletion and blunting autophagy in human cancer cells.
    Cancer biology & therapy, 2011, Dec-01, Volume: 12, Issue:11

    Topics: Adenosine Triphosphate; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Autophagy; Cell Line, Tumor; Cell Survival; Deoxyglucose; Elongation Factor 2 Kinase; Enzyme Activation; Humans; Intracellular Space; Neoplasms; Rotenone

2011
Synthesis and biodistribution of a new (99m) Tc-oxo complex with deoxyglucose dithiocarbamate for tumor imaging.
    Chemical biology & drug design, 2012, Volume: 79, Issue:3

    Topics: Animals; Carbamates; Cell Line, Tumor; Coordination Complexes; Deoxyglucose; Fluorodeoxyglucose F18; Mice; Mice, Nude; Neoplasms; Organotechnetium Compounds; Radiopharmaceuticals; Tissue Distribution; Tomography, Emission-Computed, Single-Photon

2012
A combination of 2-deoxy-D-glucose and 6-aminonicotinamide induces cell cycle arrest and apoptosis selectively in irradiated human malignant cells.
    Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine, 2012, Volume: 33, Issue:4

    Topics: 6-Aminonicotinamide; Apoptosis; Blotting, Western; CDC2 Protein Kinase; Cell Cycle; Cell Cycle Checkpoints; Cell Division; Cell Line; Cell Line, Tumor; Cell Proliferation; Cell Survival; Chemoradiotherapy; Cyclin A; Cyclin B; Cyclin-Dependent Kinases; Deoxyglucose; Flow Cytometry; G2 Phase; Humans; Neoplasms; Reactive Oxygen Species

2012
Optical molecular imaging approach for rapid assessment of response of individual cancer cells to chemotherapy.
    Journal of biomedical optics, 2012, Volume: 17, Issue:10

    Topics: 4-Chloro-7-nitrobenzofurazan; Analysis of Variance; Antineoplastic Agents; Apoptosis; Cell Survival; Choline; Cisplatin; Deoxyglucose; Fluorescent Dyes; HeLa Cells; Humans; Hydrazines; Microscopy, Fluorescence; Molecular Imaging; Neoplasms; Spheroids, Cellular

2012
Targeted cancer therapy with a 2-deoxyglucose-based adriamycin complex.
    Cancer research, 2013, Feb-15, Volume: 73, Issue:4

    Topics: Animals; Antibiotics, Antineoplastic; Cell Line, Tumor; Cell Survival; Chemistry, Pharmaceutical; Deoxyglucose; Doxorubicin; Glucose Transporter Type 1; Hep G2 Cells; Humans; MCF-7 Cells; Mice; Mice, Nude; Microscopy, Confocal; Models, Chemical; Molecular Structure; Neoplasms; Quercetin; Succinic Acid; Tumor Burden; Xenograft Model Antitumor Assays

2013
The effect of 2-desoxy-D-glucose on glycolysis and respiration of tumor and normal tissues.
    Cancer research, 1954, Volume: 14, Issue:8

    Topics: Cell Respiration; Deoxyglucose; Glucose; Glycolysis; Humans; Metabolism; Neoplasms

1954
Inhibition of anaerobic glycolysis in Ehrlich ascites tumor cells by 2-deoxy-D-glucose.
    Cancer research, 1958, Volume: 18, Issue:5

    Topics: Animals; Carcinoma, Ehrlich Tumor; Deoxyglucose; Glucose; Glycolysis; Humans; Neoplasms

1958
Certain metabolic and pharmacologic effects in cancer patients given infusions of 2-deoxy-D-glucose.
    Journal of the National Cancer Institute, 1958, Volume: 21, Issue:3

    Topics: Deoxyglucose; Encephalomyelitis; Glucose; Humans; Neoplasms

1958
Inhibition of the crabtree effect in ascites carcinoma cells by 2-deoxy-D-glucose.
    Biochemical and biophysical research communications, 1961, Jun-28, Volume: 5

    Topics: Ascites; Deoxyglucose; Glucose; Metabolism; Neoplasms

1961
A comparison of the respiratory inhibitions induced by D-glucose and 2-deoxy-D-glucose in Ehrlich ascites carcinoma cells.
    Cancer research, 1962, Volume: 22

    Topics: Animals; Ascites; Deoxyglucose; Glucose; Humans; Neoplasms

1962
Oxidative DNA damage by hyperglycemia-related aldehydes and its marked enhancement by hydrogen peroxide.
    FEBS letters, 2003, Nov-06, Volume: 554, Issue:1-2

    Topics: 8-Hydroxy-2'-Deoxyguanosine; Aldehydes; Copper; Deoxyglucose; Deoxyguanosine; Diabetes Complications; DNA Damage; Drug Synergism; Glyceraldehyde; HL-60 Cells; Humans; Hydrogen Peroxide; Hyperglycemia; Neoplasms; Oxidation-Reduction

2003
Hemopoietic cell transformation is associated with failure to downregulate glucose uptake during the G2/M phase of the cell cycle.
    Experimental cell research, 2004, Feb-15, Volume: 293, Issue:2

    Topics: Animals; Cell Cycle; Cell Transformation, Neoplastic; Deoxyglucose; Down-Regulation; Energy Metabolism; G2 Phase; Glucose; Hematopoietic Stem Cells; Humans; Jurkat Cells; Mice; Mice, Inbred C57BL; Mitosis; Monosaccharide Transport Proteins; Neoplasms; S Phase; Up-Regulation

2004
2-Deoxyglucose and radiosensitization: teaching an old DOG new tricks?
    Cancer biology & therapy, 2006, Volume: 5, Issue:7

    Topics: Deoxyglucose; Glucose; Glycolysis; Humans; Neoplasms; Radiation Tolerance

2006
Comparison of 18F-fluoromethylcholine and 2-deoxy-D-glucose in the distribution of tumor and inflammation.
    Annals of nuclear medicine, 2006, Volume: 20, Issue:8

    Topics: Animals; Autoradiography; Brain; Choline; Deoxyglucose; Fluorine Radioisotopes; Inflammation; Lung; Male; Neoplasm Transplantation; Neoplasms; Radiopharmaceuticals; Rats; Tissue Distribution; Turpentine

2006
A central role for neuronal adenosine 5'-monophosphate-activated protein kinase in cancer-induced anorexia.
    Endocrinology, 2007, Volume: 148, Issue:11

    Topics: Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Animals; Anorexia; Deoxyglucose; Drug Administration Routes; Hypothalamus; Male; Metformin; Multienzyme Complexes; Neoplasm Transplantation; Neoplasms; Neurons; Phosphorylation; Protein Serine-Threonine Kinases; Rats; Rats, Wistar; Ribonucleotides; Survival Analysis; Tumor Cells, Cultured

2007
[The effect of oxygenation on the biological behaviour of tumours].
    Orvosi hetilap, 2007, Oct-28, Volume: 148, Issue:43

    Topics: Animals; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Hypoxia; Cell Line, Tumor; Dacarbazine; Deoxyglucose; Glioblastoma; Glycolysis; Humans; Hyperbaric Oxygenation; Kidney Neoplasms; Neoplasms; Oncogene Proteins; Oncolytic Virotherapy; Temozolomide; Transplantation, Heterologous

2007
Under normoxia, 2-deoxy-D-glucose elicits cell death in select tumor types not by inhibition of glycolysis but by interfering with N-linked glycosylation.
    Molecular cancer therapeutics, 2007, Volume: 6, Issue:11

    Topics: Adenosine Triphosphate; Aerobiosis; Anaerobiosis; Cell Death; Cell Line, Tumor; Cell Survival; Deoxyglucose; Fluorodeoxyglucose F18; Glycolysis; Glycosylation; Humans; Mannose; Models, Biological; Neoplasms; Oligosaccharides; Oxygen; Oxygen Consumption; Protein Folding; Transcription Factor CHOP; Up-Regulation

2007
Energy metabolism transition in multi-cellular human tumor spheroids.
    Journal of cellular physiology, 2008, Volume: 216, Issue:1

    Topics: Adenosine Triphosphate; Animals; Cell Line, Tumor; Deoxyglucose; Energy Metabolism; Fluorescent Dyes; Glycolysis; Gossypol; Humans; Lactones; Neoplasms; Organometallic Compounds; Oxidative Phosphorylation; Oxygen; Rhodamine 123; Spheroids, Cellular

2008
2-Deoxyglucose induces Akt phosphorylation via a mechanism independent of LKB1/AMP-activated protein kinase signaling activation or glycolysis inhibition.
    Molecular cancer therapeutics, 2008, Volume: 7, Issue:4

    Topics: Adenosine Triphosphate; AMP-Activated Protein Kinase Kinases; AMP-Activated Protein Kinases; Antimetabolites; Blotting, Western; Checkpoint Kinase 1; Deoxyglucose; ErbB Receptors; Fluorescent Antibody Technique; Forkhead Box Protein O3; Forkhead Transcription Factors; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Glycolysis; Humans; Luciferases; Multienzyme Complexes; Neoplasms; Phosphatidylinositol 3-Kinases; Phosphorylation; Protein Kinases; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins c-akt; RNA, Small Interfering; Signal Transduction; Tumor Cells, Cultured

2008
Release of histamine from human leukocytes stimulated with the tumor-promoting phorbol diesters. I. Characterization of the response.
    Journal of immunology (Baltimore, Md. : 1950), 1981, Volume: 126, Issue:2

    Topics: Antibodies, Anti-Idiotypic; Calcium; Colchicine; Cyclic AMP; Deoxyglucose; Histamine Release; Humans; Immunoglobulin E; Leukocytes; Neoplasms; Phorbol Esters; Phorbols; Tetradecanoylphorbol Acetate; Time Factors

1981
Imaging of canine cancers with 18F-2-fluoro-2-deoxy-D-glucose (FDG) suggests further applications for cancer imaging in man.
    Nuclear medicine communications, 1984, Volume: 5, Issue:10

    Topics: Animals; Deoxy Sugars; Deoxyglucose; Dog Diseases; Dogs; Female; Fluorine; Fluorodeoxyglucose F18; Male; Mammary Glands, Animal; Neoplasms; Osteosarcoma; Radioisotopes; Radionuclide Imaging

1984
[Experimental study for cancer diagnosis with 18FDG: differential diagnosis of inflammation from malignant tumor].
    Kaku igaku. The Japanese journal of nuclear medicine, 1983, Volume: 20, Issue:8

    Topics: Animals; Deoxy Sugars; Deoxyglucose; Diagnosis, Differential; Fluorine; Fluorodeoxyglucose F18; Inflammation; Neoplasms; Rabbits; Radioisotopes; Radionuclide Imaging

1983
Differential uptake of 2-fluoro-2-deoxy-D-glucose.
    European journal of cancer & clinical oncology, 1983, Volume: 19, Issue:6

    Topics: Animals; Cells, Cultured; Chick Embryo; Deoxy Sugars; Deoxyglucose; Fibroblasts; Fluorodeoxyglucose F18; Humans; Mice; Neoplasms

1983
Positron imaging feasibility studies. II: Characteristics of 2-deoxyglucose uptake in rodent and canine neoplasms: concise communication.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1981, Volume: 22, Issue:10

    Topics: Animals; Deoxy Sugars; Deoxyglucose; Dog Diseases; Dogs; Liver Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Neoplasms; Rats; Rats, Inbred BUF; Sarcoma, Experimental; Tomography, Emission-Computed

1981
Optimization of cancer therapy: Part IV--Effects of 2-deoxy-D-glucose on radiation induced chromosomal damage in PHA-stimulated peripheral human leukocytes.
    Indian journal of experimental biology, 1982, Volume: 20, Issue:12

    Topics: Adult; Chromosome Aberrations; Deoxy Sugars; Deoxyglucose; DNA Repair; Humans; In Vitro Techniques; Leukocytes; Male; Neoplasms; Phytohemagglutinins

1982
SUV: standard uptake or silly useless value?
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1995, Volume: 36, Issue:10

    Topics: Blood Glucose; Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Neoplasms; Reference Standards; Tissue Distribution; Tomography, Emission-Computed

1995
Highlights of the annual meeting of the European Association of Nuclear Medicine, Düsseldorf 1994.
    European journal of nuclear medicine, 1995, Volume: 22, Issue:1

    Topics: Bone and Bones; Brain; Deoxyglucose; Europe; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Heart; Humans; Infections; Joints; Neoplasms; Nuclear Medicine; Radioimmunodetection; Radiotherapy; Societies, Medical; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon

1995
[Performance of a multispect 2 gamma camera for imaging 511-keV gamma rays].
    Nuklearmedizin. Nuclear medicine, 1995, Volume: 34, Issue:1

    Topics: Deoxyglucose; Electrons; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Gamma Rays; Humans; Models, Structural; Neoplasms; Nitrilotriacetic Acid; Organometallic Compounds; Organophosphonates; Organophosphorus Compounds; Sensitivity and Specificity; Tomography, Emission-Computed, Single-Photon

1995
Potential role of FDG-PET imaging in understanding tumor-host interaction.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1995, Volume: 36, Issue:5

    Topics: Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glucose; Models, Biological; Neoplasms; Tomography, Emission-Computed

1995
FDG-SPECT: correlation with FDG-PET.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1995, Volume: 36, Issue:6

    Topics: Adult; Aged; Brain; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Heart; Humans; Male; Middle Aged; Neoplasms; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon

1995
Triple-head SPECT with 2-[fluorine-18]fluoro-2-deoxy-D-glucose (FDG): initial evaluation in oncology and comparison with FDG PET.
    Radiology, 1995, Volume: 194, Issue:2

    Topics: Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Gamma Cameras; Humans; Models, Structural; Neoplasms; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon

1995
Neoplasms in a pediatric population: 2-[F-18]-fluoro-2-deoxy-D-glucose PET studies.
    Radiology, 1995, Volume: 194, Issue:2

    Topics: Adolescent; Child; Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Infant; Lymphoma; Neoplasms; Neuroblastoma; Sarcoma, Ewing; Tomography, Emission-Computed

1995
Cancer or inflammation? A Holy Grail for nuclear medicine.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1994, Volume: 35, Issue:10

    Topics: Citrates; Citric Acid; Deoxyglucose; Diagnosis, Differential; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Inflammation; Lymphoma; Neoplasms; Sarcoidosis; Sensitivity and Specificity; Tomography, Emission-Computed

1994
Indeterminate adrenal mass in patients with cancer: evaluation at PET with 2-[F-18]-fluoro-2-deoxy-D-glucose.
    Radiology, 1995, Volume: 194, Issue:1

    Topics: Adrenal Gland Diseases; Adrenal Gland Neoplasms; Aged; Deoxyglucose; Diagnosis, Differential; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasms; Tomography, Emission-Computed

1995
FDG-PET for the evaluation of tumor viability after anticancer therapy.
    Annals of nuclear medicine, 1994, Volume: 8, Issue:2

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasms; Radiotherapy, High-Energy; Tomography, Emission-Computed

1994
Technology for FDG SPECT with a relatively inexpensive gamma camera. Work in progress.
    Radiology, 1994, Volume: 191, Issue:2

    Topics: Adult; Brain; Costs and Cost Analysis; Deoxyglucose; Feasibility Studies; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Gamma Cameras; Heart; Humans; Male; Middle Aged; Models, Structural; Neoplasms; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon

1994
"Anatometabolic" tumor imaging: fusion of FDG PET with CT or MRI to localize foci of increased activity.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1993, Volume: 34, Issue:7

    Topics: Adult; Algorithms; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Neoplasms; Tomography, Emission-Computed; Tomography, X-Ray Computed

1993
FDG-PET in oncology: there's more to it than looking at pictures.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1993, Volume: 34, Issue:1

    Topics: Deoxyglucose; Fluorodeoxyglucose F18; Glucose; Humans; Neoplasms; Tomography, Emission-Computed

1993
FDG accumulation in tumor tissue.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1993, Volume: 34, Issue:3

    Topics: Cell Division; Deoxyglucose; Flow Cytometry; Fluorodeoxyglucose F18; Humans; Neoplasms; Tomography, Emission-Computed

1993
Detection of malignancies with SPECT versus PET, with 2-[fluorine-18]fluoro-2-deoxy-D-glucose.
    Radiology, 1996, Volume: 198, Issue:1

    Topics: Adult; Aged; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasms; Phantoms, Imaging; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon

1996
Enhanced FDG-PET tumor imaging with correlation-coefficient filtered influx-constant images.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1996, Volume: 37, Issue:2

    Topics: Artifacts; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Processing, Computer-Assisted; Male; Neoplasms; Time Factors; Tomography, Emission-Computed

1996
[Use of positron-emission tomography in oncology].
    Deutsche medizinische Wochenschrift (1946), 1996, Feb-16, Volume: 121, Issue:7

    Topics: Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Neoplasm Metastasis; Neoplasm Staging; Neoplasms; Tomography, Emission-Computed

1996
Standardized uptake values of fluorine-18 fluorodeoxyglucose: the value of different normalization procedures.
    European journal of nuclear medicine, 1996, Volume: 23, Issue:5

    Topics: Algorithms; Body Constitution; Cohort Studies; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Liver; Lung; Male; Middle Aged; Neoplasms; Prospective Studies; Reference Values; Tissue Distribution; Tomography, Emission-Computed

1996
1996 SNM annual meeting: medical problem solving.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1996, Volume: 37, Issue:8

    Topics: Artifacts; ATP Binding Cassette Transporter, Subfamily B, Member 1; Breast Neoplasms; Colorectal Neoplasms; Contrast Media; Dementia; Deoxyglucose; Eye Neoplasms; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Genetic Therapy; Head and Neck Neoplasms; Humans; Lung Neoplasms; Male; Melanoma; Neoplasms; Radioisotopes; Radiotherapy; Rhenium; Societies, Medical; Technetium; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon

1996
Fluorodeoxyglucose (FDG) and tumour metabolism.
    Nuclear medicine communications, 1995, Volume: 16, Issue:12

    Topics: Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glucose; Humans; Neoplasms; Tomography, Emission-Computed

1995
High-energy (511-keV) imaging with the scintillation camera.
    Radiographics : a review publication of the Radiological Society of North America, Inc, 1996, Volume: 16, Issue:5

    Topics: Brain; Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Gamma Cameras; Heart; Humans; Neoplasms; Phantoms, Imaging; Technetium Tc 99m Sestamibi; Technology, Radiologic; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon

1996
Positron emission tomography in oncology. General acceptance of its role is overdue.
    Cancer, 1996, Nov-15, Volume: 78, Issue:10

    Topics: Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Neoplasms; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon

1996
Evaluation of ion-implanted-silicon detectors for use in intraoperative positron-sensitive probes.
    Medical physics, 1996, Volume: 23, Issue:11

    Topics: Beta Particles; Deoxyglucose; Electrons; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Intraoperative Period; Neoplasms; Radiation Dosage; Radiometry; Radionuclide Imaging; Sensitivity and Specificity; Silicon

1996
[Cancer screening with whole-body FDG PET].
    Kaku igaku. The Japanese journal of nuclear medicine, 1996, Volume: 33, Issue:10

    Topics: Adult; Aged; Aged, 80 and over; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphoma; Male; Middle Aged; Neoplasms; Prostatic Neoplasms; Tomography, Emission-Computed

1996
The reinvention of PET.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1997, Volume: 38, Issue:1

    Topics: Deoxyglucose; Fluorine Radioisotopes; Humans; Neoplasms; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon

1997
Positron emission tomography in oncology: the most sophisticated imaging technology.
    Acta medica Croatica : casopis Hravatske akademije medicinskih znanosti, 1997, Volume: 51, Issue:1

    Topics: Carbon Radioisotopes; Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Methionine; Neoplasms; Tomography, Emission-Computed

1997
Is there a future for PET in oncology?
    European journal of nuclear medicine, 1997, Volume: 24, Issue:6

    Topics: Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Medical Oncology; Neoplasms; Sensitivity and Specificity; Tomography, Emission-Computed

1997
Development of oncology protocol using fluorine-18-FDG: one center's experience.
    Journal of nuclear medicine technology, 1997, Volume: 25, Issue:1

    Topics: Blood Glucose; Colonic Neoplasms; Deoxyglucose; Esophageal Neoplasms; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Gamma Cameras; Head and Neck Neoplasms; Humans; Image Processing, Computer-Assisted; Lung Neoplasms; Lymphoma; Neoplasm Staging; Neoplasms; Patient Education as Topic; Practice Guidelines as Topic; Problem Solving; Quality Control; Quality of Health Care; Radiation Oncology; Radiology Information Systems; Radiopharmaceuticals; Rectal Neoplasms; Stomach Neoplasms; Tomography, Emission-Computed

1997
PET FDG studies in oncology.
    Nuclear medicine and biology, 1994, Volume: 21, Issue:5

    Topics: Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Neoplasms; Radiopharmaceuticals; Tomography, Emission-Computed

1994
Molecular nuclear medicine: the best kept secret in medicine.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1997, Volume: 38, Issue:8

    Topics: Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Neoplasms; Nuclear Medicine; Radiopharmaceuticals; Societies, Medical; Tomography, Emission-Computed

1997
The importance of glucose transport activity as the rate-limiting step of 2-deoxyglucose uptake in tumor cells in vitro.
    Nuclear medicine and biology, 1998, Volume: 25, Issue:7

    Topics: 3-O-Methylglucose; Animals; Biological Transport; Cell Division; Cell Line; Deoxyglucose; Enzyme Activation; Glucose; Hexokinase; Humans; Monosaccharide Transport Proteins; Neoplasms; PC12 Cells; Rats; Tumor Cells, Cultured

1998
Hematoporphyrin derivatives potentiate the radiosensitizing effects of 2-deoxy-D-glucose in cancer cells.
    International journal of radiation oncology, biology, physics, 1999, Mar-15, Volume: 43, Issue:5

    Topics: Animals; Antimetabolites; Carcinoma, Ehrlich Tumor; Carcinoma, Squamous Cell; Deoxyglucose; Dose-Response Relationship, Drug; Drug Synergism; Glucose; Glycolysis; Hematoporphyrins; Humans; Hydrogen-Ion Concentration; Mice; Micronucleus Tests; Neoplasms; Photosensitizing Agents; Radiation-Sensitizing Agents; Radiobiology; Spheroids, Cellular; Tumor Cells, Cultured; Tumor Stem Cell Assay

1999
[Rapid increase of the use of PET in cancer investigation--but Sweden lags behind].
    Lakartidningen, 2000, Apr-19, Volume: 97, Issue:16

    Topics: Deoxyglucose; Fluorine Radioisotopes; Glucose; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasms; Rectal Neoplasms; Sweden; Tomography, Emission-Computed; United States

2000
Heterogeneity in 2-deoxy-D-glucose-induced modifications in energetics and radiation responses of human tumor cell lines.
    International journal of radiation oncology, biology, physics, 2001, Jul-15, Volume: 50, Issue:4

    Topics: Adenosine Diphosphate; Adenosine Triphosphate; Carcinoma, Squamous Cell; Deoxyglucose; DNA Damage; DNA Repair; Energy Metabolism; Glioma; Glucose; Humans; Lactic Acid; Melanoma; Micronucleus Tests; Neoplasms; Radiation Dosage; Radiobiology; Tumor Cells, Cultured

2001
Optimization of cancer therapy: Part III--Effects of combining 2-deoxy-D-glucose treatment with gamma-irradiation on normal mice.
    Indian journal of experimental biology, 1979, Volume: 17, Issue:12

    Topics: Animals; Chromosome Aberrations; Deoxy Sugars; Deoxyglucose; Gamma Rays; Male; Mice; Neoplasms

1979
Influence of energy metabolism on the repair of x-ray damage in living cells. IV. Effects of 2-deoxy-D-glucose on the repair phenomena during fractionated irradiation of yeast.
    Radiation and environmental biophysics, 1975, Dec-04, Volume: 12, Issue:4

    Topics: Deoxy Sugars; Deoxyglucose; DNA Repair; Dose-Response Relationship, Radiation; Mutation; Neoplasms; Oxygen; Radiation Genetics; Radiation-Sensitizing Agents; Saccharomyces cerevisiae; X-Rays

1975
Cancer treatment monitoring with fluorine-18 2-fluoro-2-deoxy-D-glucose and positron emission tomography: frustration or future.
    European journal of nuclear medicine, 1992, Volume: 19, Issue:11

    Topics: Animals; Combined Modality Therapy; Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Neoplasms; Tomography, Emission-Computed; Treatment Outcome

1992
Whole-body positron emission tomography: Part I. Methods and performance characteristics.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1992, Volume: 33, Issue:6

    Topics: Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Neoplasms; Time Factors; Tomography, Emission-Computed

1992
Quantitating tumor glucose metabolism with FDG and PET.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1992, Volume: 33, Issue:3

    Topics: Deoxyglucose; Fluorodeoxyglucose F18; Glycolysis; Humans; Neoplasms; Tomography, Emission-Computed

1992
PET cancer evaluations with FDG.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1991, Volume: 32, Issue:8

    Topics: Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glycolysis; Humans; Neoplasms; Tomography, Emission-Computed

1991
Assessment of response to cancer therapy using fluorine-18-fluorodeoxyglucose and positron emission tomography.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1991, Volume: 32, Issue:9

    Topics: Adult; Aged; Carcinoma, Bronchogenic; Combined Modality Therapy; Deoxyglucose; Esophageal Neoplasms; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphoma; Male; Mediastinal Neoplasms; Middle Aged; Neoplasm Recurrence, Local; Neoplasms; Rectal Neoplasms; Thyroid Neoplasms; Tomography, Emission-Computed

1991
18F-2-deoxy-2-fluoro-D-glucose uptake into human tumor xenografts. Feasibility studies for cancer imaging with positron-emission tomography.
    Cancer, 1991, Mar-15, Volume: 67, Issue:6

    Topics: Animals; Deoxyglucose; Feasibility Studies; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Mice; Mice, Nude; Neoplasm Transplantation; Neoplasms; Tissue Distribution; Tomography, Emission-Computed

1991
Current and future aspects of cancer diagnosis with PET.
    The science reports of the research institutes, Tohoku University. Ser. C, Medicine. Tohoku Daigaku, 1988, Volume: 35, Issue:1-4

    Topics: Amino Acids; Carbon Radioisotopes; Deoxyglucose; Fluorine Radioisotopes; Humans; Neoplasms; Tomography, Emission-Computed

1988
New approach to clinical evaluation of cancer chemotherapy using positron emission tomography with 18FDG (2-deoxy-2-[18F]fluoro-D-glucose).
    The science reports of the research institutes, Tohoku University. Ser. C, Medicine. Tohoku Daigaku, 1986, Volume: 33, Issue:1-4

    Topics: Adenocarcinoma; Aged; Deoxy Sugars; Deoxyglucose; Female; Fluorine; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Neoplasms; Radioisotopes; Stomach Neoplasms; Tomography, Emission-Computed

1986
[Present status and trends in radiopharmacology].
    Radiobiologia, radiotherapia, 1987, Volume: 28, Issue:2

    Topics: Antibodies, Monoclonal; Deoxyglucose; Fluorodeoxyglucose F18; Humans; Neoplasms; Radioisotopes; Radionuclide Imaging; Receptors, Dopamine; Technetium

1987
Scintigraphy with [18F]2-fluoro-2-deoxy-D-glucose of cancer patients.
    International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology, 1986, Volume: 13, Issue:1

    Topics: Adult; Aged; Deoxy Sugars; Deoxyglucose; Female; Fluorine; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasms; Radioisotopes; Radionuclide Imaging

1986
Mouse neoplasia and immunity: effects of radiation, hyperthermia, 2-deoxy-D-glucose, and Corynebacterium parvum.
    Oncology, 1985, Volume: 42, Issue:6

    Topics: Animals; Bacterial Vaccines; Body Temperature; Body Weight; Cell Line; Combined Modality Therapy; Deoxy Sugars; Deoxyglucose; Hot Temperature; Killer Cells, Natural; Lymphocyte Activation; Male; Mice; Mice, Inbred BALB C; Neoplasms; Organ Size; Phytohemagglutinins; Propionibacterium acnes; Spleen; Time Factors

1985